Lessons from Iraq on bioweapons
Iraq crisis spurs new bioweapons moves
Identification of the cellular receptor for anthrax toxin
Adjusting FDA policies to address bioterrorist threat
Genetic sleuths rush to identify anthrax strains in mail attacks
Designing a polyvalent inhibitor of anthrax toxin
Genomics and future biological weapons: the need for preventive action by the biomedical communityn
Smallpox stocks: new focus for research?
Bioweapons treaty under threat

Pathogen threat spurs research initiatives
Crystal structure of the anthrax lethal factor
US rejects stronger bioweapons treaty
Gaps remain in Japan's biodefences
Shock as labs miss anthrax samples
Anthrax: pre-publication and special issue
Senators call for biodefence boost

Anthrax Medical Progress del New England Journal of Medicine